Developing Medical Countermeasures To Treat the Acute and Chronic Effects of Ocular Chemical Toxicit

Starts:  Feb 25, 2020 08:00 (ET)
Ends:  Feb 26, 2020 13:00 (ET)
Development of therapeutics that mitigate acute and chronic corneal manifestations in response to ocular toxicants relies on the development of well-characterized experimental models with defined pathophysiology that allow for effective bridging to humans. Such models are also essential to demonstrate therapeutic efficacy. This meeting will bring together experts to discuss the current state of the field, including potential therapeutic approaches and available models for corneal injuries.

Location

Conference Center
5601 Fishers Lane
Rockville, MD 20852

Contact

Dave Yeung
391-761-7237
dy70v@nih.gov